False
August 4, 2025
Step aside, GLP-1 biologics – there’s a smaller kid in town. Meet the clinical stage Nordic company developing a small molecule TRPV1 antagonist for weight loss and diabetes treatment.
8 min read
July 17, 2025
Learning more about the people behind the 2025 Power List.
4 min read
By Rob Coker
July 16, 2025
An Oxford University-led study has found that the Parkinson’s drug pramipexole might be just the dopamine boost that treatment-resistant depression has been waiting for.
3 min read
July 7, 2025
Another Day Pharma tells us how a spider venom-derived topical peptide might be able to help those affected by erectile dysfunction and female sexual dysfunction.
11 min read
June 30, 2025
We ask experts for their views on the GLP-1 market in this exclusive eBook.
1 min read
June 20, 2025
A new approach to tackling the blood-brain barrier is attracting attention from big pharma.
5 min read
By Rob Coker
June 6, 2025
A glimpse into the research of one of the most prevalent gastrointestinal disorders worldwide, and how small molecule drug development is helping.
2 min read
By Rob Coker
May 15, 2025
Our latest news roundup reports on Trump's “most favored nation” order, the EMA’s investigation into finasteride and suicide, and Novo Nordisk’s continued R&D for obesity
4 min read
By Rob Coker
May 14, 2025
Let us not forget the important role of academic spinouts in innovating across the modalities.
3 min read
May 9, 2025
Galimedix Therapeutics explains how small molecule drug candidates could provide new treatments for Alzheimer’s disease and beyond.
4 min read
False